OTCMKTS:EXDI Exactus (EXDI) Stock Price, News & Analysis → Now Open: Crypto emergency update (From InvestorPlace) (Ad) Free EXDI Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.07▼$0.0752-Week Range N/AVolume257,300 shsAverage Volume83,144 shsMarket Capitalization$38.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Exactus alerts: Email Address Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. About Exactus Stock (OTCMKTS:EXDI)Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.Read More Ad InvestorPlaceNew crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.Just click here to sign up and be among the first to get it. EXDI Stock News HeadlinesFebruary 7, 2024 | news.yahoo.comClapham chemical attack – live: Suspect Abdul Ezedi was ‘very angry’ after sister was shot deadJune 4, 2023 | investing.comStarbreeze AB B (STZEb)April 19, 2024 | InvestorPlace (Ad)New crypto project uncovers 2,050% in 65 daysDuring the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.October 30, 2021 | finanznachrichten.deExactus Inc.: CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in WorldOctober 26, 2021 | finance.yahoo.comExactus, Inc. to Present at BIO CEO & Investor ConferenceOctober 15, 2021 | finanznachrichten.deExactus Inc.: Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversityOctober 14, 2021 | finance.yahoo.comGrand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State UniversitySee More Headlines Receive EXDI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:EXDI CUSIPN/A CIK1552189 Webwww.exactusinc.com Phone804-205-5036FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,460,000.00 Net MarginsN/A Pretax Margin-15,131.74% Return on Equity-3,272.69% Return on Assets-185.29% Debt Debt-to-Equity RatioN/A Current Ratio1.32 Quick Ratio0.82 Sales & Book Value Annual Sales$2.07 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / BookN/AMiscellaneous Outstanding Shares599,005,000Free Float209,652,000Market Cap$38.94 million OptionableNot Optionable Beta4.21 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesEmiliano AloiPresident and Interim CEOKenneth E. PuzderChief Financial Officer and DirectorAndrew JohnsonChief Strategy OfficerBobby YampolskyInterim ChairmanKey CompetitorsBright GreenNASDAQ:BGXXMannatechNASDAQ:MTEXMariMedOTCMKTS:MRMDJushiOTCMKTS:JUSHFFitLife BrandsNASDAQ:FTLFView All Competitors EXDI Stock Analysis - Frequently Asked Questions When did Exactus' stock split? Exactus's stock reverse split on the morning of Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of Exactus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). How do I buy shares of Exactus? Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EXDI) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyMan Who Predicted 2008: “This Will be Worse.”AltimetryOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exactus Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.